Is it not also true that NWBO owns the patents on the NWBO drug in combination with check point inhibitors such as and including Keytruda and not Merck? Therefore for Merck to realize benefits of the Combo they would need to come to a Royalty/Partnership agreement with NWBO or buy NWBO out.
Market Data 
Markets 
AI
